How to Increase CBD Dose (Titration): Step by Step Scheme (Table)
CBD titration without a ready dosing scheme: how long to wait between changes, what to observe, how to convert drops, and what EFSA says about safe dosing.
Titration is a methodical approach to finding the dose: in small steps, with breaks to assess the effect. In texts about cannabidiol, it is usually presented as a ready table of milligrams broken down by weeks and body weight. This article does not contain such a table, and below I explain why it is not here. However, it contains what can actually be based on data in titration: how long it takes before the effect assessment makes sense at all, what to observe between steps, how to convert the contents of the package into drops, and why the method of administration changes the result more than a slight change in the number of milligrams. The most common mistake with cannabidiol is not the wrong number but assessing the effect after three days, with changing times of administration and without any record of the baseline state. With such an approach, no dose will turn out to be correct because there is nothing to compare the result with.
KEY INFORMATION
• This article does not provide a dosing scheme in milligrams. Dose selection, especially in the case of illness or medication, is the responsibility of a doctor.
• EFSA (2026): the provisional safe dose of cannabidiol is 0.0275 mg/kg of body weight per day, which is about 2 mg for a person weighing 70 kg; safety cannot be established in individuals under 25 years of age, in pregnant and breastfeeding women, and in those taking medications.
• After repeated oral administration, the half-life of cannabidiol is 2-5 days, so the concentration stabilizes only after about two weeks.
• Assessing the effect earlier than this time cannot be distinguished from normal fluctuations in well-being.
• A fatty meal changes exposure to cannabidiol several times, meaning more than many changes in dose.
Will this article provide a ready dosing scheme in milligrams?
No, and this is a conscious decision. Publishing a table like “week one this many milligrams, week three that much” looks concrete, but in reality, it substitutes a recommendation in a place where there is no data. The text on the internet does not know the reader’s diagnosis or their medications, and these two things determine safety.
The second reason is numerical. The EFSA panel derived a provisional safe dose of cannabidiol in 2026 at a level of 0.0275 mg per kilogram of body weight per day, which is about 2 mg per day for a person weighing 70 kilograms, using an uncertainty factor of 400. This value applies only to supplements with a purity of cannabidiol of at least 98% and without nanoparticles (EFSA, EFSA Journal, 2026). Titration schemes circulating online lead to values several dozen times higher, so rewriting them here would mean providing a number contrary to the latest regulatory assessment.
The third reason directly concerns the reader of such an article. The same panel stated that the safety of cannabidiol cannot be established in individuals under 25 years of age, in pregnant and breastfeeding women, and in those taking medications. The last group is numerous among people seeking information about dosing, as they usually reach for it with a specific health problem. Instead of a number, you get a method and what is known about it from pharmacokinetics.
Why is titration based on time rather than the number of milligrams?
Because the rate at which the body establishes the concentration of cannabidiol is better known than any relationship between dose and effect. A systematic review of pharmacokinetic studies in humans included 24 works and reported the half-life of cannabidiol as 2-5 days with repeated oral administration (Millar et al., Frontiers in Pharmacology, 2018).
From this one number, the rest follows. Steady state, which is the moment when the amount taken balances the amount eliminated, is reached after four to five half-lives. With a range of 2-5 days, this gives from eight days to over two weeks. Until that time, the concentration in the blood continues to rise with an unchanged dose, so a change in well-being does not necessarily mean that more is needed.
There is also a reason that is less often discussed. A review of evidence on cannabidiol in anxiety disorders states that data in humans concern almost exclusively single administration, and there is little research on chronic administration (Blessing et al., Neurotherapeutics, 2015). In other words, there is no body of work from which a scheme broken down by weeks could be derived, as such long studies with effect measurement have hardly been conducted. A method based on time and observation is therefore not only more cautious but also fairer to the state of knowledge.
How long to wait between changes and what to record?
No less than two weeks at each stage, as it takes that long to establish the concentration. A shorter break does not answer the question of whether the change results from the dose: with unchanged procedures, the concentration during that time still increases.
The second thing is methodological and determines the value of the entire undertaking. Self-assessment from a month ago is unreliable, so comparisons must be made with a record, not with a memory. A simple note with one number daily on a simple scale is sufficient. Without a starting point, after six weeks, it is impossible to distinguish improvement from habituation.
The third principle concerns the number of variables. If the dose, time of administration, and whether the preparation is taken on an empty stomach are changed simultaneously, the result does not say anything about any of those things. One change per stage, the rest unchanged.
| Stage | Duration | What to record | What not to do |
|---|---|---|---|
| Establishing the baseline | A week before the first dose | Sleep quality, tension, severity of the target symptom on a simple scale | Start without a record of the baseline state |
| Reaching steady state | From 8 days to over 2 weeks | Tolerance, time of administration, presence of fat in the meal | Assess effectiveness after a few days |
| Post-step assessment | Not earlier than after 2 weeks | Comparison with the baseline record, not with memory | Change both dose and time of administration at once |
| Decision on the next step | After full assessment | Whether the improvement is clear, partial, or none | Increase the dose without consultation in case of illness or medications |
| Drowsiness during the day, persistent dry mouth, dizziness, or gastrointestinal discomfort are signals to return to the previous stage, not to just wait it out. | |||
The resolution of when it is worth stopping adjustments is described separately in the text about finding the dose that is sufficient.
How to convert the oil content into drops?
The conversion is based on three data points from the label: the concentration of the preparation, the volume of the bottle, and the number of drops per milliliter. The first two are always on the packaging, the third is provided by some manufacturers, and if it is not available, the entire calculation becomes an approximation.
The percentage concentration indicates how much cannabidiol is present per 100 milliliters, so the content of the bottle is concentration times volume times ten. A 5% oil in a 10-milliliter bottle contains 500 mg of cannabidiol, a 10% oil in the same bottle contains 1000 mg, and a 15% oil contains 1500 mg. To find the content of a single drop, this number is divided by the number of drops in the entire package.
With the commonly stated twenty drops per milliliter, a 10-milliliter bottle gives 200 drops. Then a drop of 5% oil carries 2.5 mg of cannabidiol, a drop of 10% oil carries twice that, and a drop of 15% oil carries correspondingly more. It is worth checking this number on the packaging, as droppers differ between products, and it depends on this number that the entire conversion is based. These calculations serve to read the label, not to determine how much to take. More broadly about the calculations themselves, the guide on converting drops and milligrams discusses.
Does the method of administration change how much cannabidiol reaches the blood?
It does, and more clearly than a slight adjustment in the number of milligrams. The influence of a meal is best documented. In a study of eight adults, the same single dose of cannabidiol was given in capsules once fasting and once after a fatty meal of about 850 kilocalories.
After the meal, the maximum concentration in the blood was on average fourteen times higher, and the total exposure calculated as the area under the curve was four times higher than when taken fasting (Birnbaum et al., Epilepsia, 2019). Therefore, the same content of the package provides a completely different exposure depending on when it is taken. A pharmacokinetic review confirms the direction: maximum concentration increases after a meal and with fatty forms.
However, it is worth knowing what is not in this data. The circulating values of sublingual bioavailability of around several percent do not come from measurement. A systematic review states directly that the absolute bioavailability of cannabidiol in humans has only been measured for the inhalation route, where it was 31%, and for other routes of administration, no one has undertaken such a trial. The practical conclusion is simple: since a meal changes exposure several times, the conditions of administration must be stabilized before any conclusions about the dose can be drawn.
When to stop increasing the dose?
When the goal has been achieved, and also when the next step has not brought anything new. The goal of titration is the lowest dose that is sufficient, not the highest that can be tolerated. This distinction determines whether the process will ever end.
Reasons to stop include: a clear improvement in the record maintained for two consecutive weeks, no additional benefit after the last change, and the appearance of symptoms that were not present before. The last point can be confused with an adjustment period, but in a steady state, a symptom that does not subside after a few days is not transient.
Separately stands the boundary before which titration ends regardless of the result. If the reason for reaching for cannabidiol is illness, if you are taking medications regularly, or if the symptom is worsening, the next step is to talk to a doctor, not another change. The regulatory assessment states clearly that with simultaneous medication, the safety of cannabidiol cannot be established, and reports of liver burden concerned just such situations. The starting point for those who are just beginning is described in the guide on CBD dosing, and the preparations for measuring in drops can be found in the oils category.
Frequently Asked Questions
How long to wait between titration steps?
At least two weeks. The half-life of cannabidiol with repeated oral administration is 2-5 days, and steady state is reached after four to five half-lives (Millar et al., 2018). An earlier assessment does not distinguish the dose effect from normal fluctuations in well-being.
Why does this article not provide a scheme in milligrams?
Because the dose selection depends on the diagnosis and medications taken, which the text does not know. EFSA stated in 2026 that the safety of cannabidiol cannot be established in individuals under 25 years of age, in pregnant and breastfeeding women, and in those taking medications. The numbers are determined by a doctor.
Does a meal change the effect of the oil?
Yes, and significantly. In a study of eight adults, a fatty meal raised the maximum concentration of cannabidiol in the blood fourteen times, and the total exposure four times compared to fasting administration (Birnbaum et al., 2019). Therefore, it is worth stabilizing the conditions of administration.
How much cannabidiol is in one drop of oil?
It depends on the concentration and the dropper. A 10-milliliter bottle contains 500 mg of cannabidiol at a concentration of 5% and 1000 mg at a concentration of 10%. With twenty drops per milliliter, this gives 200 drops in the package, so a drop of 5% oil carries 2.5 mg.
How to recognize that the dose is too high?
Drowsiness during the day, persistent dry mouth, dizziness, and gastrointestinal discomfort are typical signals. In a steady state, a symptom that does not subside after a few days is not transient and indicates a return to the previous stage, not just waiting it out.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.
Author: Michał Waluk · Published: 2026-07-10 · Updated: 2026-08-11
